<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin</rel_title>
    <rel_doi>10.1101/2020.04.02.20047050</rel_doi>
    <rel_link>http://medrxiv.org/cgi/content/short/2020.04.02.20047050</rel_link>
    <rel_abs>We report the change in the QT interval in 84 adult patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin combination. QTc prolonged maximally from baseline between days 3 and 4. in 30% of patients QTc increased by greater than 40ms. In 11% of patients QTc increased to &gt;500 ms, representing high risk group for arrhythmia. The development of acute renal failure but not baseline QTc was a strong predictor of extreme QTc prolongation.</rel_abs>
    <rel_authors>Chorin, E.; Dai, M.; Shulman, E.; Wadhwani, L.; Bar Cohen, R.; Barbhaiya, C.; Aizer, A.; Holmes, D.; Bernstein, S.; Soinelli, M.; Park, D. S.; Chinitz, L.; Jankelosn, L.</rel_authors>
    <rel_date>2020-04-03</rel_date>
    <rel_site>medrxiv</rel_site>
</item>